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Abstract. The tetramer of ethylenesulfonic acid (U-9843) is a potent inhibitor of HIV- |  RT* and possesses 
excellent antiviral activity at nontoxic doses in HIV-I infected lymphocytes grown in tissue culture. Kinetic studies 
of the HIV-1 RT-catalyzed RNA-directed DNA polymerase activity were carried out in order to determine if the 
inhibitor interacts with the template:primer or the deoxyribonucleotide triphosphate (dNTP) binding sites of the 
polymerase. Michaelis-Menten kinetics, which are based on the establishment of a rapid equilibrium between the 
enzyme and its substrates, proved inadequate for the analysis of the experimental data. The data were thus 
analyzed using steady-state Briggs-Haldane kinetics assuming that the template:primer binds to the enzyme first, 
followed by the binding of the dNTP and that the polymerase is a processive enzyme. Based on these assumptions, 
a velocity equation was derived which allows the calculation of all the specific forward and backward rate constants 
for the reactions occurring between the enzyme, its substrates and the inhibitor. The calculated rate constants are 
in agreement with this model and the results indicated that U-9843 acts as a noncompetitive inhibitor with respect 
to both the template:primer and dNTP binding sites. Hence, U-9843 exhibits the same binding affinity for the free 
enzyme as for the enzyme-substrate complexes and must inhibit the RT polymerase by interacting with a site 
distinct from the substrate binding sites. Thus, U-9843 appears to impair an event occurring after the formation of 
the enzyme-substrate complexes, which involves either an event leading up to the formation of the phosphoester 
bond, the formation of the ester bond itself or translocation of the enzyme relative to its template:primer following 
the formation of the ester bond. 
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Several polysulfates and polysulfonates have been iden- 
tified as potent inhibitors of the RNA-directed DNA 
polymerase of HIV RT* and have shown antiviral ac- 
tivity in HIV-1 infected lymphocytes grown in tissue 
culture I-~2. We have previously reported that U-9843, 
the tetramer of ethylenesulfonic acid, is a potent in- 
hibitor of the RNA and DNA-directed DNA poly- 
merase and RNase H activities of HIV-1 RT ~2. The 
compound also inhibits other RT enzyme species in- 
cluding the ones isolated from HIV-2, AMV and MLV 
retroviruses. Kinetic inhibition studies were carried out 
to establish if U-9843 interacts with the substrate bind- 
ing sites of the RNA-directed DNA polymerase func- 
tion of the HIV-1 RT enzyme. At that time the kinetic 
data were analyzed using Michaelis-Menten kinetics 
which are based on an equilibrium system and the 
analysis led us to conclude that U-9843 acts uncompeti- 
tively to noncompetitively with respect to the tem- 
plate:primer binding sites in response to increasing 
concentrations of the inhibitor. This posed a somewhat 
problematic scenario in that such a system would re- 
quire that the inhibitor binds very inefficiently to the 
free enzyme but quite efficiently to the enzyme-substrate 
complexes at low U-9843 concentrations, while at 
higher inhibitor concentrations it would bind with equal 
affinity to the free enzyme and the enzyme-substrate 
complexes. This problem was resolved in that we ap- 
plied steady-state Briggs-Haldane kinetics rather than 
Michaelis-Menten kinetics to analyze the data. The 
equations developed allow for the calculation of the 
specific forward and backward rate constants for the 
essential reactions occurring between the enzyme, its 
substrates and the inhibitor. 
Materials and methods 
The expression of HIV-I RT and its purification have 
been described 13. The enzyme was devoid of Escherichia 
coli RNase H activity and consisted of p51/p66 het- 
erodimers as evidenced by gel electrophoresis. 
The synthetic template:primers poly (rA), oligo (dT)~0, 
poly (rC), and oligo (dG)~o were purchased from Phar- 
macia. ~-[35S]-labeled dTTP and dGTP were purchased 
from Dupont NEN. Nonidet P-40 was purchased from 
Sigma. 
The standard reaction mixtures for the HIV-I RT RNA 
directed DNA polymerase assay contained 20raM 
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dithiothreitol, 60raM NaC1, 0.05% Nonidet P-40, 
10 mM MgClz, 50 mM Tris HC1, pH 8.3, 10 btM of the 
cognate ~-[35S]-labeled deoxyribonucleotide-5'-triphos- 
phate (final specific activity 1 Ci/mmol), 10 btg/ml of 
RNA template [poly (rA) or poly (rC)], 5 gg/ml of the 
appropriate primer (dT)m or (dG)m and 0.16 gg of 
purified HIV RT. The total volume of the reaction 
mixtures was 50 lal. The samples were incubated at 
37 ~ for 15 min. The reactions were terminated by the 
addition of equal volumes of 10% trichloroacetic acid. 
Incorporation of radiolabeled precursor was determined 
by collecting the precipitates on glass fiber filters, dry- 
ing, and counting the samples. 
As mentioned in the introduction, the kinetic data were 
initially analyzed using Michaelis-Menten kinetics which 
are based on a rapid equilibrium system. This analysis 
yielded ambiguous results ~2. The reason for this inade- 
quacy resides in the fact that the enzyme needs to form 
an initiation complex with the two respective substrates 
before elongation of the primer can begin. Therefore, 
no immediate equilibrium is established between the 
reactants involved. The experimental data were thus 
expanded and then analyzed using steady-state Briggs- 
Haldane kinetics. In this latter case the enzyme-substrate 
complex does not need to be in equilibrium with the 
enzyme and its substrate. However, shortly after initia- 
tion of the reaction, enzyme-substrate complex is formed 
at the same rate as it dissociates. Steady-state schemes 
including all the reaction steps to be considered here, 
yield very complex velocity equations which are imprac- 
tical to solve. For these reasons the general steady-state 
kinetic system used in this study was simplified as de- 
tailed in figure 1. The steady-state kinetics were limited 
to the reactions occurring between the enzyme and the 
substrates and rapid equilibrium kinetics were applied to 
the interactions pertaining to the inhibitor and the en- 
zyme or the various enzyme-substrate complexes. More- 
over, an ordered mechanism was assumed, whereby the 
template:primer complex binds first to the enzyme, fol- 
lowed by the addition of dNTP TM~5. The polymerase is 
a processive enzyme and, after the addition of the first 
nucleotide, translocation occurs along the template, re- 
sulting in the incorporation of further nucleotides into 
the growing chain ~4. Under these conditions the forma- 
tion of the phosphoester bond can be considered as 
irreversible as the reverse reaction occurs at an extremely 
low rate. In addition, the dissociation of the enzyme- 
product complex into its components is also negligible 
during the initial reaction phase. Thus, the enzyme- 
product does not differ from the initial enzyme- 
template:primer complex in that the former shuttles 
back to the enzyme-template:primer state and this reac- 
tion rate constant is equal to kca t o r  k2p , representing the 
turnover number (fig. 1). The pertinent rate are equi- 
librium constants and the symbols for the enzyme, the 
inhibitor and substrates used in this paper are defined in 
. ~-, " ESI. " ES1S2(EP) 
kl k'2 
E l  
k'.l EIS1 k'_2s EIS1S2 (EIP) 
Figure  1. Steady-s ta te  react ion scheme for HIV  RT.  E = enzyme; 
S] = templa te :pr imer ;  S 2 = dNTP;  Ko, Kt ,  K 2 = equi l ibr ium con-  
s tants  between the inhibi tor  [I], the enzyme and its substrates;  
EP = enzyme-produc t  complex;  EIP  = enzyme- inh ib i to r -produc t  
complex.  
figure 1. The quaternary enzyme-inhibitor-template: 
primer-dNTP complex ought to be non-productive and 
k;p --, 0. 
Thus, the HIV RT catalyzed system considered here 
consists of two substrates, $1, representing the tem- 
plate:primer, $2, representing the dNTP, and an in- 
hibitor I. The reactions between the enzyme (E) and the 
low molecular weight inhibitor (I) are deemed as diffu- 
sion controlled reactions 16-~8. Hence, the conversions 
between E and EI, ES,, and EIS~, and ES~S2 and 
EIS~ $2 occur at a much faster rate than the interconver- 
sions between the enzyme and its substrates. Thus, 
although the whole system is a steady-state one, there is 
an equilibrium between the inhibitor and the enzyme 
and the enzyme-substrate complexes ~9. The entire sys- 
tem can be expressed as shown in figure 1 where the 
equilibrium constants or K,s defined as Ko, K~, and/(2, 
respectively, are given by 
[ES1][I] [ES1S2][I] 
[ E ] [ I ]  / q  = / ( 2  = - -  ( 1 )  
K ~  [EI] ' [EISj  ' [EIS,S2] 
Using the apparent rate constants method ~9, the mecha- 
nism expressed in figure 1 can be reduced to the one 
shown in figure 2. According to Chou's graphic rules of 
enzyme kinetics 2~ the mechanism depicted in figure 2 
can be expressed by a directed graph G (fig. 3a) and the 
transformed graph G t  (fig. 3b) where E~ = E + E I ,  
E2 = ESl + EIS1, E 3 = ES1 $2 + EIS1 $2 and 
k]2 = (k +~Ko + k'+l[I])[S,] 
Ko + [~l  
k tK1 + k ' l [ I ]  
k21 - 
K~ + [I] 
(2) 
k23 - (k+2Kl + k+2[I])[S2] 
/(1 +[ I ]  
(k 2s + k+2p)K2 + ( k ' - 2 ,  + k '+2p)[I ]  
k32 = 
K 2 + [I1 
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k~[SdKd(Ko+[:[]) 
k.~K#(KI+[ I ] )  
k 1' [S 1 ][I]/(K0+[I]) 
k.l'[I]/(K1 +[I]) 
k2[Sa]K1/( KI +[I]) 
-~] (" S= k.z~K2/(K2+[I] ) "~ 
1 Jir- , 
E~+EIS~ ~S, 4+~S, s2~ 
k+s [Iy(Ka+[I]) 
Figure 2. The enzyme-catalyzed mechanism derived from figure 1 by means of the apparent rate constant method ~9. 
25 
According to Chou's  graphic rule 22~ the concentra- 
tion of  the ruth enzyme species is given by 
Arm 
[ E , , ] =  n % ( r e = l , 2  . . . . .  n) (3) 
ZU, 
i - - 1  
where eo is the total  concentration of  all enzyme species 
and 
N1 = = .~3~21 




E1 ~ E3 
(k21 + k2a) 
(b) hl 2 ~ k32 
E1 k21 2 k32 E3 
Figure 3. The graphical expression of the mechanism shown in 
figure 2. a The digraph G, and b its transformed graph G'~ 2~ 
where E 1 - E + EI, E 2 - ES 1 + EIS], E 3 ~ E S 1 S  2 4- EIS1S2 and 
k12  , k21, k23 , and k32 are given by equation 2. 
N3 = = k12k23 
Substitution of  equation 4 into equation 3 yields 
k12k23eo (5) 
[E3] = k32k21 4- k12k32 4- k12k23 
and the rate of  product  formation is (see fig. 1) 
d[P] _ k12k23(k+apK 2 4- k+2p[I])/(K 2 4- [I]) eo (6) 
dt k32k2] 4- k12k32 4- k]2k23 
Results 
The enzymatic kinetic studies with U-9843 were per- 
formed with synthetic homopolymeric  template :pr imers  
to determine the type of  inhibition pat tern on the R N A -  
directed D N A  polymerase activity of  HIV-1 RT with 
respect to the templa te :pr imer  and dNTP  binding sites. 
This activity was first studied in the presence of  varied 
concentrat ions of  the template :primer poly (rA) : (dT)lo 
and fixed concentrations of  dTTP, and vice versa in the 
presence of  varied concentrations of  dTTP and fixed 
concentrations of  poly ( rA) : (dT) l  o. Three inhibitor 
concentrations were used in addi t ion to controls con- 
taining no U-9843. The analysis of the data  was 
done via computer  applying the modified steady-state 
kinetics described under 'Materials  and methods' .  The 
experimental results are given in table 1 and the calcu- 
lated forward and backward reaction rates and equi- 
librium constants are shown in figure 4. These constants 
were derived' by fitting the experimental data  to equa- 
tion 6. We note that the calculated forward reaction 
rate constant  kl for the formation of  the enzyme-poly 
(rA):(dT)~0 complex was 4.4 x 104M 1 sec-1 and the 
rate constant  k_l for the reverse reaction was 0.3 sec 1 
in the absence of  the inhibitor. The k l/k~ ratio 
amounts thus to 6.8 laM of  template:pr imer.  Published 
estimates for this ratio range from 0.6 nM to 3 I~M 
of templa te :pr imer  although these cited values were 
calculated under the assumption that  the system is 
at equilibrium 22 24. In the presence of  U-9843, the 
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Table 1. Inhibition of HIV-1 RT poly (rA):(dT)~0-directed 
poly(dT) synthesis by U-9843 
U-9843 Poly(rA) :(dT)m dTTP d[P]/dt 
(gM) (HM) (gM) (laM • 10 6 sec-J) 
0 0.75 153 3264 
0.5 0.75 153 2844 
0.875 0.75 153 1879 
1.25 0.75 153 990 
0 1.50 153 5113 
0.5 1.50 153 3340 
0.875 1.50 153 2738 
1,25 1.50 153 1967 
0 3.00 153 7829 
0.5 3.00 153 5445 
0.875 3.00 153 3746 
1.25 3.00 153 2845 
0 4.50 153 9982 
0.5 4.50 153 6221 
0.875 4.50 153 4543 
1.25 4.50 153 3238 
0 7.5 3.85 1460 
0.25 7.5 3.85 1287 
0.5 7.5 3.85 ] 157 
1 7.5 3.85 960 
0 7.5 7.7 2662 
0.25 7.5 7.7 1937 
0.5 7.5 7.7 1775 
1 7.5 7.7 1098 
0 7.5 15.2 4806 
0.25 7.5 15.2 3235 
0.5 7.5 15.2 3000 
1 7.5 15.2 1800 
0 7.5 38.5 8268 
0.25 7.5 38.5 6162 
0.5 7.5 38.5 4400 
1 7.5 38.5 3158 
Enzyme = 0.0274 gM, d[P]/dt = ~tM x 10 6 of dTMP incorpo- 
rated per sec. 
k 1 = 4.4 X 104 M "1 s e c  -1 
k. 1 = 0 . 3  s e c  -1 
~'e = 0.77 ~M 
E P  1 =  ~ !12( ) 
K 1 = 0.67 ~M = 0.61 ~M 
k' 1 = 2.6 x 104 M -1 sec  -1 k' 2 = 0.86 x 104 M "1 s e c  "I 
El k'_,= o.2~ sec-1 EIS1 k'~,=o2o sec'l EIS1S2 
Figure 4. Inhibition of poly (rA):(dT)10-directed poly (dT) syn- 
thesis by U-9843; steady-state kinetic parameters. 
corresponding constants were reduced to k'l = 2.6 • 
104M -1 sec ~ and k' =0.26sec  i The forward - I  
and backward rate constants for the formation and 
dissociation of the ternary enzyme-poly (rA):(dT)l  0- 
dTTP complex were k2 = 3 • 104 M -~ sec 1 and k_2, = 
0.84sec -~. The corresponding rate constants in the 
presence of the inhibitor U-9843 were 0.86 • 10 4 M i 
sec -~ for k~, assessing the formation of the enzyme-U- 
9843-poly (rA):(dT)lo-dTTP complex and 0.29 sec 1 
for k '2 , ,  assessing its dissociation. The translocation 
rate or turnover number  k2p for the enzyme was 
0.9 sec 1 for the control reaction and essentially 0 for 
k;p, the corresponding value for the enzyme-inhibitor- 
template:primer-dNTP complex. The value for k2p is 
somewhat lower than the one reported by Reardon 15 
(14 sec 1) but in good agreement with the one calcu- 
lated by Anderson and Coleman 25 (1.2 sec-1). More- 
over, the inhibition constants or K~s calculated for the 
enzyme (Ko), the enzyme-template:primer (K1) and the 
enzyme-template:primer-dTTP (K2) complexes with the 
inhibitor were 0.77, 0.67, and 0.61 gM of U-9843, re- 
spectively. The overall fitting error was 0.5 • 10 s It is 
apparent that the values for the equilibrium constants 
or/( is  are of the same magnitude and this indicates that 
U-9843 acts as a noncompetitive inhibitor with respect 
to both the poly (rA):(dT)~o and the dTI 'P  binding sites 
of the enzyme. 
Analogous experiments were carried out in the presence 
of varied amounts of the homopolymeric tem- 
plate:primer poly (rC):(dG)lo and a constant concen- 
tration of dGTP or vice versa in the presence of varied 
concentrations of dGTP and a constant amount  of the 
cognate template:primer. The experimental results are 
shown in table 2 and the calculated rate constants and 
equilibrium constants are reported in figure 5. The 
forward rate constant kl for the association of the 
RT-poly (rC):(dG)~o complex was 5.9 x l04 M l sec 1 
and its dissociation rate constant k 1 was 0.39 sec 1. 
In the presence of the inhibitor, k'l, the forward reac- 
tion rate for the formation of the enzyme-U-9843- 
template:primer complex was 2.5 x 104 M 1 see i and 
the value for k ' l ,  the reverse reaction, was 0.23 sec -1. 
In addition, the rate constant k2 for the formation of 
enzyme-template:primer-dGTP complex was 2.8 x 104 
M l sec ~ and the rate constant k_2s for the reverse 
reaction was 0.82 s e c l .  In the presence of the inhibitor 
the rate constant k~ assessing the association of the 
enzyme-U-9843-template:primer-dGTP complex was 
0.77 x l& M -~ sec ~ and k22~, the corresponding disso- 
ciation rate constant was 0.27sec -~. The turnover 
number or translocation rate k2e was 0.4 sec i for the 
control reaction in this system and k'2p, the analogous 
value for the enzyme-U-9843-template:primer-dNTP 
complex was essentially 0. The equilibrium constants 
were 0.47 ~tM of U-9843 for K0, the enzyme-U-9843 
complex, 0.45 ~tM for K~, the enzyme-U-9843-poly 
(rC) :(dG)~0 complex and 0.31 gM for K2, the enzyme- 
U-9843-template:primer-dGTP complex. The overall 
fitting error was 1 x 10 4. The Kis are of equal value 
and indicate that the inhibitor acts as a noncompetitive 
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Table 2. Inhibition of HIV-1 RT poly (rC):(dG)~o-directed poly 
(dG) synthesis by U-9843 
U-9843 Poly(rC) :(dG)l o dGTP d[P]/dt 
(~tM) (~tM) (~tM) (~tM • i0-6 sec -~) 
0 0.45 73 561 
0.25 0.45 73 439 
0.5 0.45 73 231 
1 0.45 73 92 
0 0.75 73 1061 
0.25 0.75 73 793 
0.5 0.75 73 445 
1 0.75 73 238 
0 1.50 73 1826 
0.25 1.50 73 1232 
0.5 1.50 73 646 
1 1.50 73 353 
0 3 73 2973 
0.25 3 73 2013 
0.5 3 73 1159 
1 3 73 598 
0 6 73 3684 
0.25 6 73 2427 
0.5 6 73 1813 
1 6 73 887 
0 7.5 3.65 1506 
0.25 7.5 3.65 764 
0.5 7.5 3.65 514 
l 7.5 3.65 296 
0 7.5 7.3 2725 
0.25 7.5 7.3 1667 
0.5 7.5 7.3 1126 
1 7.5 7.3 668 
0 7.5 14.8 3378 
0.25 7.5 14.8 2047 
0.5 7.5 14.8 1464 
1 7.5 14.8 794 
0 7.5 36.5 4766 
0.25 7.5 36.5 2861 
0.5 7.5 36.5 2023 
1 7.5 36.5 1337 
Enzyme = 0.0274 gM, d[P]/dt = ~M • 10 6 of dGMP incorpo- 
rated per sec. 
$1 --" po ly  (rC) : (dG)1o 
S 2 --- d G T P  
k I = 5,9 x 104 M "1 sec "1 
k. 1 = 0.39 sec "1 
K 0 = 0.47 ~M 
/<'1 = 2"5 x 104 M'I  sec ' l  
E=: ;,oo23 E . $ e c  "1 
~ E P  ~2,ooo2socl !1 2( ) 
K 1 = 0.45 gM = 0.31 g M  
k~2 = 0.77 x 104 M "1 sec "1 
IS1 ~- w2,=o.~.T " E ISIS2 
Figure 5. Inhibition of poly (rC) :(dG)10-directed poly (dG) syn- 
thesis by U-9843; steady-state kinetic parameters. 
inhibitor with respect to the poly (rC) :(dG)m and dGTP  
binding sites. Moreover,  the K~ and/<2 values calculated 
for the poly (rC):(dG)~0-catalyzed D N A  polymerase 
system are of  the same magnitude as the ones obtained 
for the poly (rA):(dT)~o-catalyzed system demonstrat-  
ing that the potency of  U-9843 is independent of  the base 
composit ion o f  the template:primers.  
Discussion 
The inhibition kinetics of  U-9843 on the RNA-direc ted  
D N A  polymerase domain of  HIV-1 RT was studied 
with respect to the nucleic acid and dNTP binding sites 
using synthetic homopolymeric  template:primers.  The 
analysis of  the experimental results was carried out 
using somewhat modified steady-state Briggs-Haldane 
kinetics as detailed under 'Materials  and methods' .  
These kinetics take into consideration that 1) the reac- 
tion is ordered in that the template :pr imer  binds first to 
the enzyme and is followed by the addit ion of  dNTP; 
2) the enzyme-product  complex elongated by one base 
does not dissociate into free enzyme and product  but is 
recycled back to the enzyme-template:pr imer state by 
the process of  translocation and the polymerase is, 
therefore, processive; 3) the formation of  the phospho- 
ester bond and the concomitant  release of pyrophos-  
phate is irreversible; and 4) the binding of  the inhibitor 
to the free enzyme or the various enzyme-substrate 
complexes follows rapid equilibrium kinetics. The re- 
suits obtained are consistent with this model. Equation 
6 allows the calculation of  the essential rate constants 
and equilibrium constants as it relates the amount  of  
product  formed by the RT enzyme to its two substrates, 
the template :pr imer  and the dNTP, and the inhibitor. 
The steady-state Briggs-Haldane kinetic analysis ap- 
plied here shows that the system is indeed a steady-state 
one and not  an equilibrium system for the following 
reasons: The Ki values or equilibrium constants Ko, K1, 
K2 are of  similar magnitude for all the enzyme-U-9843 
and enzyme-U-9843-substrate complexes regardless of  
whether the reaction was directed by either poly 
( r A ) ' ( d T ) l  o or po ly( rC) : (dG) lo ,  and these values are 
independent of  the inhibitor concentration. Earlier 
analyses, using Michaelis-Menten kinetics, incorrectly 
suggested that  U-9843, at low concentrations acts as an 
uncompetitive inhibitor with respect to the nucleic acid 
binding site of  the enzyme. The steady-state analysis 
presented here, now clearly shows that U-9843 acts as 
a noncompeti t ive inhibitor with respect to both the 
template :pr imer  and dNTP binding sites and that  this 
inhibition pat tern is independent of  the U-9843 concen- 
tration. Moreover,  the results show that  U-9843 inter- 
acts with a site distinct from either the templa te :pr imer  
and the dNTP binding sites. Therefore, U-9843 appears 
to impair  an event leading up to the formation of  the 
phosphoester  bond, the formation of  the ester bond  per 
se, or the event of  t ranslocation of  the enzyme relative 
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to the t emp la t e :p r imer  fol lowing the fo rmat ion  o f  the 
ester bond.  
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